
It is well recognized that bipolar disorder is associated with elevated vascular risk, that this risk exceeds what can be explained by traditional cardiovascular risk factors (e.g. obesity, hypertension), that this risk is associated with bipolar disorder subtypes and with mood symptom burden, and that this risk is observed internationally. Perhaps less recognized are the implications that the bipolar-vascular link has on biomarker discovery, novel therapeutic approaches, and stigma reduction efforts.


Objectives
The goal of the ISBD Vascular Task Force is to summarize the state of the literature regarding vascular factors and bipolar disorder, and to articulate an agenda for future progress. This task force will undertake efforts to consolidate, distill, contextualize, and critique the extant literature, and will take steps toward knowledge translation and dissemination through a primary manuscript, web-based lecture series, and engagement of stakeholders including colleagues in other branches of medicine, allied health professions, and consumer advocacy groups, for the purpose of maximizing impact.
Leads
Benjamin Goldstein,
Canada
Jess Fiedorowicz,
Canada
Members of Task Force
Hilary Blumberg, USA
David Bond, USA
Pao-Huan Chen, Taiwan
Lisa Eyler, USA
Eric Goldwaser, USA
Fabiano Gomes, Canada
Jody Greaney, USA
Tomas Hajek, Canada
Kody Kennedy, Canada
Susan McElroy, USA
Roger McIntyre, Canada
Megan Mio, Canada
Abigail Ortiz, Canada
Miguel Prieto, Chile
Elysha Ringin, Australia
Louisa Sylvia, USA
Shang-Ying Tsai, Taiwan
Task Force Updates
Publications:
2020
Goldstein BI, Baune BT, Bond DJ, et al. Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders. Bipolar Disord. 2020;22:440–460.
Task Force Resources




